Systematic Review
Copyright ©The Author(s) 2019.
World J Meta-Anal. Jun 30, 2019; 7(6): 269-289
Published online Jun 30, 2019. doi: 10.13105/wjma.v7.i6.269
Table 5 Patient- and treatment- associated parameters after multivisceral resection for gastric cancer
StudyResection margin (R0 vs R1)Most common resected organsLymph node involvementAgeBlood transfusionComplications (AI) (Re-OP)Other prognostic factors
Carboni et al[39], 2005R0 61.5%; R1 27.7%; R2 10.8%Spleen: 48%; Pancreas: 43%; Colon: 25%86.2%61NR(1.5%) (1.5%)Lymph-node involvement and metastatic disease
Colen et al[37], 2004NRSpleen: 62%; Pancreas 57%; Colon: 24%NR67.5NR0% (NR)NR
D'Amato et al[38], 2004R0: 69%Pancreas: 62%; Colon: 12%NRNRNR(0%) (NR)NR
Jeong et al[43], 2009R0: 78.3%; R+: 21.7%Spleen: 47%; Pancreas: 61%; Colon: 24%N+: 90.1%59NR(6.7%) (11%)Lymph-node and lymphovascular involvement
Kim et al[35], 2009R0: 43%; R1: 15%; R2: 74%Spleen: 38%; Pancreas: 29%; Colon: 56%NRNRNR(2.9%) (0%)histologic type, M stage, peritoneal metastasis, curability and treatment groups
Martin et al[36], 2002R0: 100%Spleen: 67%; Pancreas: 19%; Colon: 6%; Liver: 4% Gallbladder: 7%N0: 35% N+: 65%66NR(NR) (NR)Lymph-node involvement and > pT3
Oñate-Ocaña et al[32], 2008R0: 58.1%; R1: 18.9%; R2: 23%Spleen: 68%; Pancreas: 26%; Colon: 12%; Liver: 9%NRNRNR(NR) (NR)NR
Ozer et al[44], 2009NRPancreas: 54%; Colon: 32%; Liver: 18%NR58NR(8.9%) (NR)Advanced age, lymph node involvement, and resection of more than 1 additional organ were significant prognostic factors for survival.
Persiani et al[46], 2008R0: 320; R1: 39; R2: 29%Spleen: 84%; Pancreas: 25%; Colon: 10%NR63.4NR(NR) (NR)Splenectomy, D2 lymphadenectomy, and age greater than 64 yr were the only factors predictive of overall morbidity
Shchepotin et al[33], 1998NRSpleen: 43%; Pancreas: 69%; Colon: 45% Liver: 29%N+: 38.8%NRNR(3.7%) (NR)NR
Isozaki et al[45], 2000NRPancreas + Spleen: 36%; Pancreatoduodenectomy: 7%N0 = 13%; N1 = 36%; N2 = 25%; N3 = 12%NRNR(NR) (NR)Location of the tumor, lymph node metastasis, histological depth of invasion, and extent of lymph node dissection
Molina et al[40], 2019R0: 94%Pancreas (49%); Spleen (34%) Liver (29%).N+: 80%64,5NR(NR) (NR)Lymph-node involvement and R1-status
Mita et al[42], 2017R0: 82.5%; R1: 17.5%Spleen 29.1%; Pancreas: 46.6%; Colon: 13.6%; Liver: 11.7%N+: 84.5%70NR(NR) (NR)Resection status
Vladov et al[38], 2015R0: 75%Spleen: 76.7%; Pancreas:40%; Colon: 18.3%; Liver 15%NRNRNR(NR) (NR)NR
Tran et al[31], 2015R1: 15.5Spleen: 48%; Pancreas:27% Liver 14% Colon: 13%N0: 34.5%64NR(11.5%) (13.8%)MVR with pancreatectomy, was significantly associated with decreased survival, along with T-stage, N stage, perineural invasion, and
Pacelli et al[34], 2013R0: 38.4%Pancreas 46; Colon 43N+: 89.3%NRNR(7%) (NR)Lymph-node involvement and incomplete resection